Brain scans of people with MS can help us understand the impact of COVID.

Published Date: 02 Mar 2023

People with multiple sclerosis should have regular brain MRIs. These images are now being used to show the effects of the coronavirus.

Read Full News

Latest News

Nothing to Shrug About: Shoulder Reproducibility with SGRT

A pilot study suggests open-face SGRT immobilization is feasible for HN radiotherapy, with shoulder reproducibility similar to conventional masks.

Paget's Disease Mimicking Metastasis: A Diagnostic Pitfall

A case of rising PSA and widespread sclerotic bone lesions turned out to be Paget's disease, not metastasis—avoiding unnecessary ADT and bone harm.

Efficacy of Lu177-PSMA in Pretreated Older Veterans

Lutetium177-PSMA-617 is a radioligand therapy for PSMA-positive metastatic castrate resistant prostate cancer after receipt of at least 1 ARPI.

Care Coordination for Evaluation of Possible Malignancy

VHA Directive 1415 mandates that all VA systems implement formal, documented processes with clear roles to manage suspected cancer cases.

S1 Episode 2: Seeing Gout Clearly: Advances in Diagnosis and Imaging

Drs Kenneth Saag and Nicola Dalbeth explore how crystal analysis and imaging advances can sharpen gout diagnosis and guide patient care.

Common Causes of Vertigo in Primary Care: Part 3

Clinicians should be prepared to identify vestibular migraine, the rare Ménière disease, and persistent postural perceptual dizziness, a functional disorder.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

A pilot study suggests open-face SGRT immobilization is feasible for HN radiotherapy, with shoulder reproducibility similar to conventional masks.

A case of rising PSA and widespread sclerotic bone lesions turned out to be Paget's disease, not metastasis—avoiding unnecessary ADT and bone harm.

Lutetium177-PSMA-617 is a radioligand therapy for PSMA-positive metastatic castrate resistant prostate cancer after receipt of at least 1 ARPI.

VHA Directive 1415 mandates that all VA systems implement formal, documented processes with clear roles to manage suspected cancer cases.

Drs Kenneth Saag and Nicola Dalbeth explore how crystal analysis and imaging advances can sharpen gout diagnosis and guide patient care.

Clinicians should be prepared to identify vestibular migraine, the rare Ménière disease, and persistent postural perceptual dizziness, a functional disorder.

News All Time

The Looming 100-Million Cancer Workforce Crisis

Global workforce inequities are widening the cancer survival gap. Prof David Kerr highlights the stark realities and calls for an improved training approach.

Are Smart Glasses the Future of Collaborative Surgery?

Orthopedic surgeon Amgad Nakhla is using smart glasses in theater to bring remote expertise into com-plex cases and support real-time decisions.

Thyroid: A Year in Review

Drs Kaniksha Desai and Anupam Kotwal discuss thyroid: a year in review.

Fast Five Quiz: PPF Management

What do you know about the management for progressive pulmonary fibrosis? Test your knowledge with this quick quiz.

CT Radiation Risk: Is it Time to Rethink Imaging?

Two high-impact studies link routine CT scans to significant lifetime cancer risks. Dr Maurie Markman discusses why we can no longer ignore the data.

Preview: New Thyroid Nodule Guidelines

Drs Kaniksha Desai and Victor Bernet discuss the new guidelines for thyroid nodules.

Migraine and Stroke: What's the Real Risk?

Neurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

More patients of all ages skip sentinel lymph node biopsy, get less aggressive RT or none at all

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

Registry tracked incidence, prognostic impact of early hemodynamic valve deterioration

Pancreatic Cancer Risk Much Higher for Certain Group, Study Suggests

Long-term follow-up of low-risk pancreatic cystic lesions may be necessary

Tile-Based Radiation Tops Standard for Resected Brain Metastases

Approach significantly improved local control, and longer survival observed in trial

Trump's Doc Says President Is in 'Excellent Health' as BMI Approaches Obesity Range

Report shows Trump has a BMI of 29.7 and was given advice on diet and physical activity

ASNR Expert Video Roundtable: Expert Video Rountable from the American Society of Neuroradiology

Breakthroughs in Gastrointestinal Cancers From ASCO 2026

Breakthroughs in pancreatic cancer, novel drug combinations, and the role of observation in colorectal cancer are among the advances in gastrointestinal cancer at ASCO 2026 selected by Dr Manish Shah.

Jun 19 2026 This Week in Cardiology

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week’s podcast.

Planning Pregnancy in Crohn’s: Expert Insights

Dr Laura Sahyoun discusses the challenges of pregnancy in Crohn’s disease, with clinical guidance to help optimize care.

Recommended News For You

How artificial intelligence could significantly improve the prognosis for cancer patients.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

A prostate cancer risk prediction algorithm could help target men at highest risk

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

Cancerous breast tissue glows in new AI-enhanced MRI images

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

Recommended Articles For You

Structural Variant Landscapes in Solid Tumors: Clinical and Molecular Perspectives 

Ex Vivo Engineered Hematopoietic Therapies for Functional Restoration of Blood-Cell Production 

Long-Term Care After Cancer Remission: Clinical Strategies, Evidence, and Future Directions 

A Revolutionary Guide to Calculating Absolute Neutrophil Counts 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Significant differences in breast cancer care still exist, but surgeons can change.

2.

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

3.

Breast awareness: What to look for in your self-exam

4.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

5.

Triplet Could Become a New Standard in Tough-to-Treat CLL

1.

Bone Marrow Niche Regeneration Strategies in Hematology

2.

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts

3.

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition

4.

Patient Management for Bone Marrow Functional Recovery Pathways

5.

Innovative Directions in Hematology Across Clinical Settings

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Evidence-Based Oncology

2.

Navigating the Complexities of Ph Negative ALL - Part VII

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

4.

Navigating the Complexities of Ph Negative ALL - Part VIII

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot